Ben Tre Pharmaceutical JSC

Ben Tre Pharmaceutical JSC EBITDA per Share

The EBITDA per Share of Ben Tre Pharmaceutical JSC (DBT.VN) as of Nov 1, 2026 is 2,797.28 VND. In the previous year, EBITDA per Share was 3,806.94 VND — a change of -26.52% (lower).

EBITDA per Share

2,797.28VND

YoY

-26.52%

Last updated:

EBITDA per Share of Ben Tre Pharmaceutical JSC is 2024 2,797.28 VND. EBITDA per Share of Ben Tre Pharmaceutical JSC was 2023 3,806.94 VND. It decreases by -26.52% lower compared to the previous year.

The Ben Tre Pharmaceutical JSC EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2014
1,579.11 VND
Jan 1, 2015
576.00 VND
Jan 1, 2020
2,431.93 VND
Jan 1, 2021
1,064.36 VND
Jan 1, 2022
2,045.88 VND
Jan 1, 2023
3,806.94 VND
Jan 1, 2024
2,797.28 VND
The Ben Tre Pharmaceutical JSC EBITDA per Share history
YEAREBITDA per ShareYoY
2,797.28VND-26.52%
3,806.94VND+86.08%
2,045.88VND+92.22%
1,064.36VND-56.23%
2,431.93VND+322.21%
576.00VND-63.52%
1,579.11VND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ben Tre Pharmaceutical JSC Stock analysis

What does Ben Tre Pharmaceutical JSC do? Ben Tre Pharmaceutical JSC manufactures and distributes pharmaceutical products, including medicinal products through its subsidiaries. The company wholesales, imports, and exports pharmaceuticals, materials, chemicals, packagings, and biological products. It also retails drugs and trades supplements, medical equipment, supplies, and machinery. The firm rents commercial space for additional revenue. Its primary customers are healthcare providers, pharmacies, and medical institutions requiring pharmaceuticals and medical supplies. The company's revenue streams include pharmaceutical manufacturing, wholesale distribution, import/export services, retail drug sales, and commercial space rentals. Key segments are pharmaceuticals, medical equipment, and biological products. The firm serves healthcare sectors through its subsidiaries and direct retail channels. Revenue is generated from both domestic and international trade activities. Ben Tre Pharmaceutical JSC's products include pharmaceuticals, medicinal products, medical equipment, and supplements. The company's brands are not specified in the business description. It targets healthcare providers, pharmacies, and medical institutions as its main buyers. The firm's operations span manufacturing, distribution, retail, and commercial leasing within the pharmaceutical and medical sectors. Ben Tre Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ben Tre Pharmaceutical JSC stock

EBITDA per Share of Ben Tre Pharmaceutical JSC is 2,797.28 VND in 2024.

EBITDA per Share of Ben Tre Pharmaceutical JSC changed from 3,806.94 VND to 2,797.28 VND, representing a -26.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Ben Tre Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Ben Tre Pharmaceutical JSC

All Key Metrics — Ben Tre Pharmaceutical JSC